Tharimmune, Inc. Made Big Gain
Thu, Aug 21, 2025 at 07:55 PM

Tharimmune, Inc. (THAR:NASDAQ) soared at $4.97, representing a gain of 38.4%. On Thu, Aug 21, 2025, THAR:NASDAQ hit a New 2-Week High of $4.97. The stock got featured on our News Catalysts scanner on Wed, Aug 20, 2025 at 10:55 AM in the 'EARNINGS' category. From Thu, Aug 07, 2025, the stock recorded 40.00% Up Days and 45.45% Green Days
About Tharimmune, Inc. (THAR:NASDAQ)
Hillstream BioPharma Inc is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron-mediated cell death for...
Top 10 Gainers:
- Hempacco Co., Inc. (HPCO:NASDAQ), 350%
- Aptorum Group Limited (APM:NASDAQ), 234.65%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 97.3%
- Smart for Life, Inc. (SMFL:NASDAQ), 92.31%
- Gaxos.ai Inc. (GXAI:NASDAQ), 51.65%
- Luda Technology Group Limited (LUD:NYSEMKT), 49.89%
- SelectQuote, Inc. (SLQT:NYSE), 41.53%
- Sol-Gel Technologies Ltd. (SLGL:NASDAQ), 40.22%
- Tharimmune, Inc. (THAR:NASDAQ), 38.44%
- Equillium, Inc. (EQ:NASDAQ), 36.84%